Funding, M&A, exec moves and hiring — matched to your market, with the people to call.See plans →
Humigent Raises Series A to Build AI Intelligence for Life Sciences. The funding will accelerate product innovation and expand their portfolio of specialized solutions.
PRIVATEJul 29, 2026•11 days ago
Round Type
Series A
Investors
First Rays VenturesZ21 Ventures
Description
Humigent, an AI-native company, announced the successful close of its Series A funding round, with participation from Z21 Ventures and First Rays Ventures. The funding will accelerate product innovation, expand Humigent's portfolio of specialized agentic solutions, and scale AI deployments across life sciences organizations. Humigent combines a proprietary 30-billion-parameter life sciences language model and specialized AI agents to create trusted insights for enterprises.
Related People
Suggested for you
3 contactsVerified contactsBiswarupa, Executive Director Commercial AI hidden hidden
Funding Insights
Based on industry dataTypical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations
VC-backed spending patterns
VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers